Journal
MOLECULAR CANCER
Volume 16, Issue -, Pages -Publisher
BMC
DOI: 10.1186/s12943-017-0600-4
Keywords
Tumor heterogeneity; Cancer stem cell; Stemness; Tumor microenvironment
Categories
Funding
- AMC
- Dutch Cancer Society [2009-4416, 2012-5735]
- MLDS [FP13-07]
- Gravitation program ZonMW
Ask authors/readers for more resources
Tumor heterogeneity represents an ongoing challenge in the field of cancer therapy. Heterogeneity is evident between cancers from different patients (inter-tumor heterogeneity) and within a single tumor (intra-tumor heterogeneity). The latter includes phenotypic diversity such as cell surface markers, (epi)genetic abnormality, growth rate, apoptosis and other hallmarks of cancer that eventually drive disease progression and treatment failure. Cancer stem cells (CSCs) have been put forward to be one of the determining factors that contribute to intra-tumor heterogeneity. However, recent findings have shown that the stem-like state in a given tumor cell is a plastic quality. A corollary to this view is that stemness traits can be acquired via (epi) genetic modification and/or interaction with the tumor microenvironment (TME). Here we discuss factors contributing to this CSC heterogeneity and the potential implications for cancer therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available